{
  "url": "https://openlegislation.uk/health-service-medicines-control-of-prices-and-supply-of-information-amendment-regulations-2015/note",
  "json_url": "https://openlegislation.uk/health-service-medicines-control-of-prices-and-supply-of-information-amendment-regulations-2015/note.json",
  "legislation": "uksi/2015/233",
  "legislation_title": "The Health Service Medicines (Control of Prices and Supply of Information) (Amendment) Regulations 2015",
  "legislation_url": "https://openlegislation.uk/health-service-medicines-control-of-prices-and-supply-of-information-amendment-regulations-2015",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Regulations)\nThese Regulations, which apply to the United Kingdom, amend the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007 (“the 2007 Regulations”) and the Health Service Branded Medicines (Control of Prices and Supply of Information) (No.2) Regulations 2008 (“the 2008 Regulations”).\nRegulation 2 amends the 2007 Regulations, under which a manufacturer or supplier of a branded health service medicine that is not a member of the Pharmaceutical Price Regulation Scheme must provide information to the Secretary of State.\nRegulation 2(2) corrects a typographical error in the 2007 Regulations.\nRegulation 2(3)(a) and 2(3)(b) disapplies the information requirements to manufacturers or suppliers who have joined the Pharmaceutical Price Regulation Scheme.\nRegulation 2(3)(c) clarifies that manufacturers must provide information on the quantity of each presentation.\nRegulation(3)(d) amends the definition of “presentation” so that it only includes a relevant medicine. A relevant medicine means a medicine which is both a prescription only medicine and a branded health service medicine.\nRegulation 2(4) inserts a provision which requires manufacturers and suppliers to record and keep specified information on the sale of their presentations. The Secretary of State may request this information if he believes that the relevant manufacturer or supplier has breached the 2007 Regulations or the 2008 Regulations.\nRegulation 2(5) enables the Secretary of State to demand a penalty in the circumstances where a manufacturer or supplier breaches any of the information requirements in the 2007 Regulations.\nRegulation 3 amends the 2008 Regulations, which control the maximum price of presentations that are supplied for the health services’ use by any manufacturer or supplier who is not a member of the Pharmaceutical Price Regulation Scheme.\nRegulation 3(2) amends the definition of “presentation” so that it only includes a relevant medicine.\nRegulation 3(3) states that the percentage reduction element of the maximum price calculation in regulation 2 of the 2008 Regulations does not apply to any presentation which was procured under one or more framework agreements under the Public Contracts Regulations 2006 where the framework agreement was entered into on or before 31st December 2013 or was entered into following a tender which closed on or before 31st December 2013 and until the day after the day at the end of which the relevant framework agreement expires.\nThe Impact Assessment has been prepared and is available at https://www.gov.uk/government/consultations/branded-medicines-controlling-prices. Copies may also be obtained from the Department of Health, Wellington House, 133-155 Waterloo Road, London, SE1 8UG.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2015/233/note",
    "retrieved_at": "2026-10-28T23:47:46.682227+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}